Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era

Clinical and Experimental Ophthalmology

Volumn 39, Issue 2, 2011, Pages 99-104

  Lai, Timothy Y Y ^a   Wong, Raymond L M ^a   Luk, Fiona O J ^a   Chow, Vanissa W S ^a   Chan, Carmen K M ^a   Lam, Dennis S C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AIDS; CMV retinitis; Factor; HIV; Mortality; Risk

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BLURRED VISION; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; EYE EXAMINATION; FEMALE; FOLLOW UP; HERPES ZOSTER OPHTHALMICUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MICROANGIOPATHY; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; VISION; VISUAL ACUITY; VITREOUS FLOATERS;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; EYE INFECTIONS, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV PROTEASE INHIBITORS; HONG KONG; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES; VISUAL ACUITY;

EID: 79952646541     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02400.x     Document Type: Article

References (33)

1. World Health Organization. AIDS epidemic update: November 2009.
2. Moraes HV. Ocular manifestations of HIV/AIDS. Curr Opin Ophthalmol 2002; 13: 397-403.
3. Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol 2004; 49: 131-57.
4. Jeng BH, Holland GN, Lowder CY, Deegan WF 3rd, Raizaman MB, Meisler DM. Anterior segment and external ocular disorders associated with human immunodeficiency virus disease. Surv Ophthalmol 2007; 52: 329-68.
5. Babu RB, Sudharshan S, Kumarasamy N, Therese L, Biswas J. Ocular tuberculosis in acquired immunodeficiency syndrome. Am J Ophthalmol 2006; 142: 413-16.
6. Ng WT, Versace P. Ocular association of HIV infection in the era of highly active antiretroviral therapy and the global perspective. Clin Experiment Ophthalmol 2005; 33: 317-29.
7. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997; 124: 227-33.
8. Holtzer CD, Jacobson MA, Hadley WK etal. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS 1998; 12: 1931-3.
9. Jacboson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30: 231-3.
10. Kahraman G, Krepler K, Franz C etal. Seven years of HAART impact on ophthalmic management of HIV-related patients. Ocul Immunol Inflamm 2005; 13: 213-18.
11. Jabs DA, Van Natta ML, Holbrook JT etal. Longitudinal study of the ocular complications of AIDS. 1. Ocular diagnoses at enrollment. Ophthalmology 2007; 114: 780-6.
12. Jabs DA, Van Natta ML, Holbrook JT etal. Longitudinal study of the ocular complications of AIDS. 2. Ocular examination results at enrollment. Ophthalmology 2007; 114: 787-93.
13. Chiou SH, Liu CY, Hsu WM etal. Ophthalmic findings in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2000; 33: 45-8.
14. Miyamoto C, Yashiro S, Nagata Y, Nagataki S. Ocular complications in patients infected with human immunodeficiency virus seen at the Acquired Immunodeficiency Syndrome Clinical Center. Nippon Gakkai Zasshi 2001; 105: 483-7.
15. Ausayakhun S, Watananikorn S, Ittipunkul N, Chaidaroon W, Patikulsila P, Patikulsila D. Epidemiology of the ocular complications of HIV infection in Chiang Mai. J Med Assoc Thai 2003; 86: 399-406.
16. Uemura A, Yashiro S, Takeda N, Oka S. Ocular complications in patients with human immunodeficiency virus infection. Nippon Ganka Gakkai Zasshi 2006; 110: 698-702.
17. Gharai S, Venkatesh P, Garg S, Sharma SK, Gharai PG, Vohra R. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol 2008; 15: 264-71.
18. Wang J, You Q, Yang H etal. Retinal findings in Chinese patients with HIV infection. Ophthalmic Res 2008; 40: 98-100.
19. Lin YC, Yang CH, Lin CP etal. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese. Ocul Immunol Inflamm 2008; 16: 83-7.
20. Pathai S, Deshpande A, Gilbert C, Lawn SD. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study. BMC Infect Dis 2009; 9: 158.
21. Jabs DA. AIDS and ophthalmology in 2004. Arch Ophthaomol 2004; 122: 1040-2.
22. Jabs DA. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc 1995; 93: 623-83.
23. Tay Kearne ML, Jabs DA. Ophthalmic complications of HIV infection. Med Clin North Am 1996; 80: 1471-92.
24. Ho PC, Farzavandi SK, Kwok SK etal. Ophthalmic complications in AIDS in Hong Kong. J Hong Kong Med Assoc 1994; 46: 117-20.
25. Kestelyn PG, Cunningham ET Jr. HIV/AIDS and blindness. Bull World Health Organ 2001; 79: 208-13.
26. Awan HR, Adala HS. Ophthalmic manifestations of AIDS in Kenya. Ophthal Pracat 1996; 2: 92-102.
27. Lewallen S, Courtright P. HIV and AIDS and the eye in developing countries: a review. Arch Ophthalmol 1997; 115: 1291-5.
28. Pivetti-Pezzi P, Tamburi S, Accoriniti M etal. Immunological and viral markers of HIV infection and retinal microangiopathy. Eur J Ophthalmol 1993; 3: 138-42.
29. Furrer H, Barloggio A, Egger M etal. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma. Ophthalmology 2003; 110: 432-6.
30. Geier SA, Perro C, Klauss V etal. HIV-related ocular microangiopathic syndrome and cognitive functioning. J Acquir Immune Defic Syndr 1993; 6: 252-8.
31. Dunn JP, Yamashita A, Kempen JH, Jabs DA. Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina 2005; 25: 759-66.
32. Goldberg DE, Smithen LM, Angelilli A, Freeman WR. HIV-associated retinopathy in the HAART era. Retina 2005; 25: 633-49.
33. Karavellas MP, Lowder CY, Macdonald C, Avila CP Jr, Freeman WR. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998; 116: 169-75.